Please select the option that best describes you:

What scenario would flipped dosing versus standard dosing of ipilimumab + nivolumab be beneficial in metastatic melanoma?  

CheckMate 511 trial showed reduced toxicity with flipped dosing of ipilimumab/ nivolumab (ipi 1 mg/kg and nivo 3 mg/kg instead of ipi 3 mg/kg and nivo 1 mg/kg) with similar progression free survival.



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more